Eventide Asset Management - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 62 filers reported holding IMMUNE DESIGN CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q3 2016$1,364,000
-7.1%
180,0000.0%0.08%
-7.8%
Q2 2016$1,469,000
-37.2%
180,0000.0%0.09%
-31.3%
Q1 2016$2,340,000
-35.3%
180,0000.0%0.13%
-27.6%
Q4 2015$3,614,000
+91.7%
180,000
+16.5%
0.18%
+64.5%
Q3 2015$1,885,000
-11.3%
154,501
+50.1%
0.11%
-4.3%
Q2 2015$2,125,000
+22.8%
102,904
+25.6%
0.12%
-11.5%
Q1 2015$1,730,00081,9570.13%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders